iScienceImmunologyPeer-reviewed journal article
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome.
Cansu Cimen BozkusiD, Matthew BrowniD, Leandra G. Velazquez, Marcus Thomas, Eric A. Wilson, Timothy J. O’DonnelliD, Anna KaminskaiD, Denis RuchnewitziD, Douglas Geertz, Yonina BykoviD, Julia KodyshiD, Kasopefoluwa Y. OguntuyoiD, Vladimir RoudkoiD, David Hoyos, Komal Srivastava, Giulio KleineriD, Hala AlshammaryiD, Neha Karekar, Christopher B. McClainiD, Ramya Gopal, Kai NieiD, Diane Marie Del ValleiD, Daniela Delbeau-ZagelbaumiD, Denise RodrigueziD, Jessica Setal, , Nina BhardwajiD
- Citations
- 6
- FWCI
- 1.49
- Field percentile
- top 19%
Abstract
As SARS-CoV-2 variants continue to emerge capable of evading neutralizing antibodies, it has become increasingly important to fully understand the breadth and functional profile of T cell responses to determine their impact on the immune surveillance of variant strains. Here, sampling healthy individuals, we profiled the kinetics and polyfunctionality of T cell immunity elicited by mRNA vaccination. Modeling of anti-spike T cell responses against ancestral and variant strains of SARS-CoV-2 suggested that epitope immunodominance and cross-reactivity are major predictive determinants of T cell immunity. To identify immunodominant epitopes across the viral proteome, we generated a comprehensive map of CD4+ and CD8+ T cell epitopes within non-spike proteins that induced polyfunctional T cell responses in convalescent patients. We found that immunodominant epitopes mainly resided within regions that were minimally disrupted by mutations in emerging variants. Conservation analysis across historical human coronaviruses combined with in silico alanine scanning mutagenesis of non-spike proteins underscored the functional importance of mutationally-constrained immunodominant regions. Collectively, these findings identify immunodominant T cell epitopes across the mutationally-constrained SARS-CoV-2 proteome, potentially providing immune surveillance against emerging variants, and inform the design of next-generation vaccines targeting antigens throughout SARS-CoV-2 proteome for broader and more durable protection. One Sentence SummaryPolyfunctional CD8+ and CD4+ T cells directed against SARS-CoV-2 target mutationally constrained regions of the viral proteome.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations
- Clonal dissection of immunodominance and cross-reactivity of the CD4+ T cell response to SARS-CoV-2
J. S. Low, D. Vaqueirinho, … F. Sallusto·bioRxiv·Mar 23, 2021
- Bioinformatic analysis of B and T cell epitopes from SARS-CoV-2 Spike, Membrane and Nucleocapsid proteins as a strategy to assess possible cross-reactivity between emerging variants, including Omicron, and other human coronaviruses
Diana Laura Pacheco-Olvera, Stephanie Saint Remy-Hernández, … Constantino III Roberto López-Macías·bioRxiv·Feb 16, 2022
- Computational assessment of the spike protein antigenicity reveals diversity in B cell epitopes but stability in T cell epitopes across SARS-CoV-2 variants
A. Ge, M. Rioux, A. A. Kelvin·bioRxiv·Mar 25, 2021
- Antigenic evolution on global scale reveals potential natural selection of SARS-CoV-2 by pre-existing cross-reactive T cell immunity
Chengdong Zhang, Xuanxuan Jin, … Tianyi Qiu·Frontiers in MicrobiologyPeer-reviewed·May 18, 2021
- SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein.
S. Parn, K. Savsani, S. Dakshanamurthy·bioRxiv·Apr 5, 2022